GRANNER DARYL K 4

4 · OSI PHARMACEUTICALS INC · Filed Feb 5, 2009

Form 4

Period: 2009-02-03

Director

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2009-02-03−7,500→ 2,500 total
Exercise: $15.02From: 2004-03-19Exp: 2013-03-18→ Common Stock (7,500 underlying)
Exercise/Conversion
Common Stock
2009-02-03$15.02/sh+7,500$112,650→ 26,537 total
Exercise/Conversion
Stock Option (Right to Buy)
2009-02-03−2,500→ 0 total
Exercise: $20.31From: 2001-03-15Exp: 2010-03-15→ Common Stock (2,500 underlying)
Exercise/Conversion
Common Stock
2009-02-03$20.31/sh+2,500$50,783→ 19,037 total
Sale
Common Stock
2009-02-03$42.10/sh−10,000$420,954→ 16,537 total

Footnotes (4)

[F1]Transaction made pursuant to a 10b5-1 plan dated March 3, 2008.
[F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $42.00 to $42.76 per share. The Reporting Person will provide upon request of the staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F3]One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months.
[F4]Includes only options with the same termination date.

Documents

1 file